LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
24.01
-0.22 (-0.91%)
At close: Feb 27, 2026, 4:00 PM EST
24.50
+0.49 (2.04%)
After-hours: Feb 27, 2026, 4:18 PM EST
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $607.43 million as of February 27, 2026.
Market Cap
607.43M
Enterprise Value
296.62M
1-Year Change
n/a
Ranking
Category
Stock Price
$24.01
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $607.43M, an increase of 101.47%. That is a compound annual growth rate of 353.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 607.43M | 7.86% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 631.68M |
| Rigel Pharmaceuticals | 630.58M |
| Zura Bio | 628.08M |
| Lexicon Pharmaceuticals | 627.81M |
| Allogene Therapeutics | 624.75M |
| Alto Neuroscience | 611.70M |
| MeiraGTx Holdings | 608.51M |
| YD Bio | 603.34M |